GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS

GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS

SUMMARY Introduction: Several genetic mutations affect the first-line triple therapy for Helicobacter pylori. We aimed to study the most common genetic mutations affecting the metronidazole and clarithromycin therapy for H. pylori-infected Egyptian patients. Patients and Methods: In our study, we...

Full description

Bibliographic Details
Main Authors: Iman RAMZY, Hassan ELGAREM, Iman HAMZA, Doaa GHAITH, Tamer ELBAZ, Waleed ELHOSARY, Gehan MOSTAFA, Mohammad A. Mohey Eldin ELZAHRY
Format: Article
Language:English
Published: Universidade de São Paulo (USP)
Series:Revista do Instituto de Medicina Tropical de São Paulo
Subjects:
16s rRNA
Metronidazole resistance
rdxA gene
Clarithromycin resistance.
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652016005000269&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652016005000269&lng=en&tlng=en

Similar Items